Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations.

Publication Year: 2023

DOI:
10.2147/NSS.S201994

PMCID:
PMC9879039

PMID:
36713640

Journal Information

Full Title: Nat Sci Sleep

Abbreviation: Nat Sci Sleep

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Clinical Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure Prof. Luigi Ferini-Strambi reports personal fees for lectures and advisory board work from Idorsia. Prof. Alessandro Silvani is an inventor in Italian patent application n. 102022000013894 related to a novel dual orexin receptor agonist. The other authors report no potential conflicts of interest in this work."

Evidence found in paper:

"This was not an industry-supported study. This study was partially supported by a fund from the Italian Ministry of Health “Ricerca Corrente” (RC n. 2773803) (G.L., R.F.). Maria P Mogavero and Alessandro Silvani are co-first authors for this study."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025